HQS Quantum Simulations has been awarded a €2.5 million ($2.6M USD) grant from the European Innovation Council (EIC) Transition Program to advance its project, HQS-NextNMR, aimed at revolutionizing NMR (Nuclear Magnetic Resonance) spectroscopy. The funding will support the development of a cutting-edge tool for high-precision molecular structure identification, with applications in personalized medicine and beyond.
The project builds on HQS’s expertise in quantum algorithms and simulations, initially developed under the EU-funded FET Open project AVaQus. HQS has created a prototype for NMR spectrum analysis that operates on conventional hardware, offering improved accuracy over existing solutions. The next phase will focus on adapting this technology for low-field magnetic resonance, expanding the utility of benchtop NMR devices.
Dr. Iris Schwenk, COO and Co-Founder of HQS, emphasized the transformative potential of the technology: “Our software tool will provide highly accurate spectral predictions, enabling the analysis of complex molecular structures and biological mixtures with unprecedented precision. This positions NMR as a key technology for the future of personalized medicine.” The EIC Transition Program supports SMEs and start-ups in validating and scaling innovative technologies. HQS was selected from 413 applicants, reflecting the project’s potential impact.
For more details, view a news release provided posted on the HQS website here.
January 29, 2025
